Cart
sales@molnova.com
Telazorlimab
CAS No. 2126777-87-3
Telazorlimab( —— )
Catalog No. M36870 CAS No. 2126777-87-3
Telazorlimab (GBR-830) is a humanized monoclonal antibody targeting the OX40 co-stimulatory receptor on activated T cells, and is used to treat lupus erythematosus and atopic dermatitis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 375 | Get Quote |
|
| 5MG | 535 | Get Quote |
|
| 10MG | 852 | Get Quote |
|
| 25MG | 1224 | Get Quote |
|
| 50MG | 1647 | Get Quote |
|
| 100MG | 2178 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTelazorlimab
-
NoteResearch use only, not for human use.
-
Brief DescriptionTelazorlimab (GBR-830) is a humanized monoclonal antibody targeting the OX40 co-stimulatory receptor on activated T cells, and is used to treat lupus erythematosus and atopic dermatitis.
-
DescriptionTelazorlimab (GBR-830) is a humanized monoclonal antibody against OX40 costimulatory receptor on activated T cells. Telazorlimab can be used for the research of autoimmune diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorImmunology/Inflammation related
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2126777-87-3
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Guttman-Yassky E, et, al. GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis. J Allergy Clin Immunol. 2019 Aug;144(2):482-493.e7.?
molnova catalog
related products
-
Clozic
Clozic exhibits reversible anti-proliferative effects and can be used in studies about serving as a potential anti-arthritic agent.
-
AMI-5
Eosin yellowish is a versatile red dye used in cosmetics, pharmaceuticals, textiles, etc.
-
S-Gboxin
S-Gboxin is an active analogue of Gboxin with potent antitumour activity. S-Gboxin inhibits the growth of mouse and human glioblastoma (GBM IC50: 470 nM).
